Skip to main navigation Skip to search Skip to main content

Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease

  • Jean Frédéric Colombel
  • , Bruce E. Sands
  • , Christopher Gasink
  • , Benjamin Yeager
  • , Omoniyi J. Adedokun
  • , James Izanec
  • , Tony Ma
  • , Long Long Gao
  • , Scott D. Lee
  • , Stephan R. Targan
  • , Subrata Ghosh
  • , Stephen B. Hanauer
  • , William J. Sandborn
  • Icahn School of Medicine at Mount Sinai
  • LLC
  • Intercept Pharmaceuticals
  • Temple University Health System
  • Johnson & Johnson
  • University of Washington
  • Cedars-Sinai Medical Center
  • Northwestern University
  • University of California at San Diego

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science